Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.
- 1 January 1988
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 85 (1) , 213-217
- https://doi.org/10.1073/pnas.85.1.213
Abstract
Homologous restriction factor (HRF) is a 65-kDa membrane protein that inhibits transmembrane channel formation by the membrane-attack complex of complement and by the complement component C9-related cytolytic lymphocyte protein. Stimulation of resting peripheral human lymphocytes with the anti-CD3 monoclonal antibody OKT3 has been shown to induce cytotoxicity in the CD8+ subpopulation. As demonstrated here, OKT3 stimulation also induces expression of cell-surface HRF by CD4+ and CD8+ T lymphocytes. The small proportion of Leu 19+ natural killer lymphocytes present in peripheral blood mononuclear cells was found to express HRF prior to stimulation. Whereas unstimulated peripheral blood mononuclear cells were susceptible to lysis by the membrane-attack complex or by the C9-related protein, OKT3-stimulated peripheral blood mononuclear cells were relatively resistant to both the membrane-attack complex and C9-related protein. This acquired resistance was abrogated by blocking surface HRF with F(ab'')2 anti-HRF, suggesting that resistance was due to lymphocyte-membrane HRF. By using solid-phase anti-HRF, a 65-kDa protein was isolated from the activated peripheral blood mononuclear cells and shown to be capable of conferring upon sheep erythrocytes the characteristic activity of human HRF.Keywords
This publication has 21 references indexed in Scilit:
- Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes.The Journal of Experimental Medicine, 1987
- T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.The Journal of Immunology, 1985
- Specific release of proteoglycans from human natural killer cells during target lysisNature, 1985
- Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.The Journal of Immunology, 1985
- Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.The Journal of Immunology, 1985
- Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.Proceedings of the National Academy of Sciences, 1983
- The ninth component of human complement: purification and physicochemical characterization.The Journal of Immunology, 1980
- Membrane attack complex of complement: a structural analysis of its assembly.The Journal of Experimental Medicine, 1980
- Interaction of Cytotoxic T Lymphocytes and Target CellsPublished by S. Karger AG ,1979
- The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).The Journal of Experimental Medicine, 1976